Integrin-mediated mTOR signaling drives TGF-β overactivity and myxomatous mitral valve degeneration in hypomorphic fibrillin-1 mice
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci183558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Fu Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Fibrillin-1, Signal Transduction, Mitral Valve Prolapse, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, NIH.
Abstract (Originalsprache)
Mitral valve prolapse is often benign, but progression to mitral regurgitation may require invasive intervention and there is no specific medical therapy. An association of mitral valve prolapse with Marfan syndrome resulting from pathogenic FBN1 variants supports the use of hypomorphic fibrillin-1 mgR mice to investigate mechanisms and therapy for mitral valve disease. mgR mice developed severe myxomatous mitral valve degeneration with mitral regurgitation by 12 weeks of age. Persistent activation of TGF-β and mTOR signaling along with macrophage recruitment preceded histological changes at 4 weeks of age. Short-term mTOR inhibition with rapamycin from 4 to 5 weeks of age prevented TGF-β overactivity and leukocytic infiltrates, while long-term inhibition of mTOR or TGF-β signaling from 4 to 12 weeks of age rescued mitral valve leaflet degeneration. Transcriptomic analysis identified integrins as key receptors in signaling interactions, and serologic neutralization of integrin signaling or a chimeric integrin receptor altering signaling prevented mTOR activation. We confirmed increased mTOR signaling and a conserved transcriptome signature in human specimens of sporadic mitral valve prolapse. Thus, mTOR activation from abnormal integrin-dependent cell–matrix interactions drives TGF-β overactivity and myxomatous mitral valve degeneration, and mTOR inhibition may prevent disease progression of mitral valve prolapse.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA.
- Department of Biomedical Engineering, Yale University, New Haven, Connecticut, USA.
- Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
- Department of Surgery and.
- Columbia Surgical Cardiovascular Research Institute, Columbia University, New York, New York, USA.
- Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
- NIH
Zitieren
APA
Gao, F., Chen, Q., Mori, M., Li, S., Ferrari, G., Krane, M., Fan, R., Tellides, G., Liu, Y., & Geirsson, A. (2025). Integrin-mediated mTOR signaling drives TGF-β overactivity and myxomatous mitral valve degeneration in hypomorphic fibrillin-1 mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci183558
Vancouver
Gao F, Chen Q, Mori M, Li S, Ferrari G, Krane M, et al. Integrin-mediated mTOR signaling drives TGF-β overactivity and myxomatous mitral valve degeneration in hypomorphic fibrillin-1 mice. Journal of Clinical Investigation. 2025. doi:10.1172/jci183558
BibTeX
@article{Gao2025,
author = {Gao, Fu and Chen, Qixin and Mori, Makoto and Li, Sufang and Ferrari, Giovanni and Krane, Markus and Fan, Rong and Tellides, George and Liu, Yang and Geirsson, Arnar},
title = {Integrin-mediated mTOR signaling drives TGF-β overactivity and myxomatous mitral valve degeneration in hypomorphic fibrillin-1 mice},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci183558}
}
EUVIMED